We have joined A-Alpha Bio, Dyno Therapeutics, Boltz, and GSK in a mission to solve the bottleneck holding AI protein engineering back: data!
More on the Atlas Consortium:
Cradle
@cradlebio
AI software platform for protein engineering.
Engineer better proteins, faster.
- Moving from rational design to ML-driven protein engineering changes how you think about selecting variants. We built Cradle around that shift, and here's what it looks like in practice:
- Scientists kicking off a campaign using @cradlebio often have little to start with: a weakly functional lead and a target product profile. The gap between the two seems huge. Here's how we get better binding—often alongside additional gains—without a single labeled training
- New partnership announcement! Lundbeck partners with Cradle to discover and optimize brain disorder treatments. The collaboration’s initial focus will focus on two antibody programs targeting CNS diseases. Full press release: cradle.bio/blog/lundbeck
